Two other CR genes with the highest mutation rates were SETD2 (2.94% vs 3.76%) and DNMT3A (1.05% vs 1.37%), which did not differ significantly in prevalence between the astrocytoma and glioblastoma groups. Here, DNMT3A is linked to astrocytoma (excluding glioblastoma).